These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 6443847

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Experimental study of the dynamics of the formation of protective antibodies to the antigens of the slime of Pseudomonas aeruginosa].
    Iushkova NA, Stanislavskiĭ ES, Landsman NM.
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):78-83. PubMed ID: 6405564
    [Abstract] [Full Text] [Related]

  • 27. Treatment of experimental burn wound sepsis by postburn immunization with polyvalent Pseudomonas antigen.
    Nance FC, Hines JL, Fulton RE, Bornside GH.
    Surgery; 1970 Jul; 68(1):248-53. PubMed ID: 10483476
    [Abstract] [Full Text] [Related]

  • 28. Serial determination of complement and specific antibody titres in Pseudomonas aeruginosa infection.
    Petrás G, Füst G, Adám MM.
    Acta Microbiol Hung; 1984 Jul; 31(2):141-51. PubMed ID: 6464660
    [Abstract] [Full Text] [Related]

  • 29. Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide.
    Ward CK, Inzana TJ.
    J Immunol; 1994 Sep 01; 153(5):2110-21. PubMed ID: 8051416
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Immunologic study of the cellular components of pseudomonas pyocyaneus. II. Extraction of purified lipopolysaccharide, its characteristics and elaboration of an erythrocyte O-diagnosticum].
    Kolker II, Stanislavskiĭ ES, Zarubina EK, Elagina EK, Kaliaev AV.
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep 01; (12):113-07. PubMed ID: 828824
    [Abstract] [Full Text] [Related]

  • 39. [Extracellular antigens of Pseudomonas aeruginosa].
    Shchetinina VN.
    Mikrobiol Zh (1978); 1985 Sep 01; 47(6):36-40. PubMed ID: 3939838
    [No Abstract] [Full Text] [Related]

  • 40. Synthetic peptide vaccine development: measurement of polyclonal antibody affinity and cross-reactivity using a new peptide capture and release system for surface plasmon resonance spectroscopy.
    Cachia PJ, Kao DJ, Hodges RS.
    J Mol Recognit; 2004 Sep 01; 17(6):540-57. PubMed ID: 15386623
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.